Michele Ghidini

Prognostic Survival Associated With Left-Sided vs Right-Sided Colon Cancer

Fausto Petrelli, Gianluca Tomasello, Karen Borgonovo et al. · JAMA Oncology · 2016 · 722 citations

Trifluridine/tipiracil versus placebo in patients with heavily pretreated metastatic gastric cancer (TAGS): a randomised, double-blind, placebo-controlled, phase 3 trial

Kohei Shitara, Toshihiko Doi, Mikhail Dvorkin et al. · The Lancet Oncology · 2018 · 495 citations

Gastrointestinal Oncology, Trifluridine/tipiracil Versus Placebo, Medicine +9

Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial

Shukui Qin, Minshan Chen, Ann‐Lii Cheng et al. · The Lancet · 2023 · 415 citations · Full text

Surgical Oncology, Hepatology, Medicine +8

Effect of Pathologic Tumor Response and Nodal Status on Survival in the Medical Research Council Adjuvant Gastric Infusional Chemotherapy Trial

Elizabeth Smyth, Matteo Fassan, David Cunningham et al. · Journal of Clinical Oncology · 2016 · 298 citations · Full text

The sexist behaviour of immune checkpoint inhibitors in cancer therapy?

Andrea Botticelli, Concetta Elisa Onesti, Ilaria Grazia Zizzari et al. · Oncotarget · 2017 · 112 citations · Full text